Armstrong Advisory Group’s Pfizer PFE Stock Holding History

Armstrong Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$250K	Buy	10,400 +40	+0.4%	+$1.05K	0.02%	220
2026 Q1	$291K	Sell	10,360 -124	-1%	-$3.3K	0.02%	195
2025 Q4	$261K	Buy	10,484 +3,328	+47%	+$83.9K	0.02%	196
2025 Q3	$182K	Sell	7,156 -1,764	-20%	-$43.5K	0.01%	227
2025 Q2	$216K	Buy	8,920 +2,895	+48%	+$67.5K	0.02%	199
2025 Q1	$160K	Hold	6,025	–	–	0.01%	214
2024 Q4	$160K	Buy	6,025 +152	+3%	+$4.12K	0.01%	214
2024 Q3	$170K	Sell	5,873 -1,052	-15%	-$30.7K	0.01%	205
2024 Q2	$194K	Buy	6,925 +480	+7%	+$13.2K	0.02%	186
2024 Q1	$186K	Hold	6,445	–	–	0.02%	187
2023 Q4	$186K	Sell	6,445 -1,190	-16%	-$36K	0.02%	187
2023 Q3	$253K	Buy	7,635 +463	+6%	+$16.4K	0.03%	145
2023 Q2	$263K	Sell	7,172 -1,075	-13%	-$41.8K	0.03%	144
2023 Q1	$336K	Sell	8,247 -508	-6%	-$21.9K	0.04%	115
2022 Q4	$449K	Buy	+8,755	New	+$420K	0.06%	95

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Armstrong Advisory Group's PFE Position: Q2 2026 in Review

Armstrong Advisory Group increased its Pfizer (PFE) stake by 0.39% in Q2 2026, buying an estimated $1.05K and bringing the position to 10,400 shares worth $250K. The position accounts for 0.02% of the portfolio, ranked #220.

Armstrong Advisory Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $449K in Q4 2022. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Armstrong Advisory Group held 10,400 shares of Pfizer worth $250K as of Q2 2026.
Armstrong Advisory Group bought 40 Pfizer shares in Q2 2026, an estimated $1.05K.
Pfizer made up 0.02% of Armstrong Advisory Group's portfolio in Q2 2026, its #220 holding.
Armstrong Advisory Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
Armstrong Advisory Group's Pfizer position peaked at $449K in Q4 2022.
557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.